Navigation Links
Cord Blood America Reduces "Afford-A-Cord" Program Charges; New Buyers Anticipated

LAS VEGAS, May 12, 2011 /PRNewswire/ -- Cord Blood America, Inc. ( (OTC BB: CBAID), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that it is reducing the monthly payment in its unique "Afford-A-Cord" storage program from $29 a month to $19.

Afford-A-Cord reduces the initial cost of storing umbilical cord blood stem cells from $2075 to $495 plus medical courier service.  The Afford-A-Cord program is offered as an additional payment option to the Company's long standing traditional payment programs.  It accounted for four percent of the Company's revenues in the most recent fiscal year.  

"The data tells the story.  It was four percent of our revenues, and without a doubt, these families would otherwise not have bought cord blood storage at all.  The Afford-A-Cord program is strictly designed to bring in new buyers that historically could not afford to store stem cells.  By reducing the monthly fee even further, our expectation is that this program will become an even greater portion of our business portfolio," said Matthew Schissler, Cord Blood America co-founder and CEO.  

"Parents and grandparents who realize the importance of storing a baby's umbilical cord blood stem cells, but who are strapped financially, still should have the opportunity to participate in this potentially live saving program," Mr. Schissler said.  "No other company offers such a low entry point, one that will allow a greater number of families to store their child's stem cells and, with the lowering of the monthly fee, we hope to provide this service to more families whose financial situations are difficult in the current economy."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAID) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of diseases, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at For investor information, visit

   Paul Knopick
   E & E Communications

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cord Blood America Announces BioCells, Inc., Which it Acquired in 2010, is Opening Office in Miami, Florida and 5 New Offices in Argentina Soon
2. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
3. ThermoGenesis Announces China Customer Implements Cord Blood Products
4. Cord Blood America: Shareholders Approve Common Stock Reverse Split
5. Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression to be Presented at the American Psychiatric Association Annual Meeting
6. Cord Blood America: Court Grants Motion to Dismiss at Lawsuit Aimed at Blocking Acquisition
7. Orexigen® Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring
8. New England Cord Blood Bank: Umbilical Cord Tissue Banking
9. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
10. Cord Blood America Announces Affiliate Program to Educate on Value of Umbilical Cord Blood Stem Cell Storage
11. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board meeting ... I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space ... membership in ARCS Alumni Hall of Fame . ASTER Labs is a ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology:
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Biology News(10 mins):